MUHAMMAD SOHAIL to Pacemaker, Artificial
This is a "connection" page, showing publications MUHAMMAD SOHAIL has written about Pacemaker, Artificial.
Connection Strength
11.380
-
Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT Trial. JACC Clin Electrophysiol. 2021 01; 7(1):50-61.
Score: 0.616
-
Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular-matrix envelope. Pacing Clin Electrophysiol. 2020 03; 43(3):341-349.
Score: 0.589
-
Reduced bacterial adhesion with parylene coating: Potential implications for Micra transcatheter pacemakers. J Cardiovasc Electrophysiol. 2020 03; 31(3):712-717.
Score: 0.586
-
Interventions to Prevent CIED Infections: More or Less? J Am Coll Cardiol. 2018 12 18; 72(24):3110-3111.
Score: 0.541
-
Infection Management. Card Electrophysiol Clin. 2018 12; 10(4):601-607.
Score: 0.540
-
Approach to Diagnosis of Cardiovascular Implantable-Electronic-Device Infection. J Clin Microbiol. 2018 07; 56(7).
Score: 0.524
-
International survey of knowledge, attitudes, and practices of cardiologists regarding prevention and management of cardiac implantable electronic device infections. Pacing Clin Electrophysiol. 2017 Nov; 40(11):1260-1268.
Score: 0.497
-
Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J Nucl Cardiol. 2019 06; 26(3):958-970.
Score: 0.496
-
Strategies to prevent infections associated with cardiovascular implantable electronic devices. Expert Rev Med Devices. 2017 May; 14(5):371-381.
Score: 0.484
-
Management of bacteremia in patients living with cardiovascular implantable electronic devices. Heart Rhythm. 2016 11; 13(11):2247-2252.
Score: 0.461
-
Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection: Evidence From a Large US Payer Database 1-Year Post Implantation. Circ Arrhythm Electrophysiol. 2016 08; 9(8).
Score: 0.459
-
Usefulness of sonication of cardiovascular implantable electronic devices to enhance microbial detection. Am J Cardiol. 2015 Apr 01; 115(7):912-7.
Score: 0.412
-
Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):137-44.
Score: 0.410
-
Cardiovascular implantable electronic device infections in left ventricular assist device recipients. Pacing Clin Electrophysiol. 2014 Feb; 37(2):225-30.
Score: 0.375
-
Microbiology and pathogenesis of cardiovascular implantable electronic device infections. Circ Arrhythm Electrophysiol. 2012 Apr; 5(2):433-41.
Score: 0.340
-
Cardiovascular implantable electronic device infection: a stepwise approach to diagnosis and management. Cleve Clin J Med. 2011 Aug; 78(8):529-37.
Score: 0.325
-
Contemporary management of cardiovascular implantable electronic device infections. Expert Rev Anti Infect Ther. 2010 Jul; 8(7):831-9.
Score: 0.301
-
Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008 Jan; 83(1):46-53.
Score: 0.253
-
Management of infected pacemakers and implantable cardioverter-defibrillators. Intern Med J. 2007 Jul; 37(7):509-10; author reply 510.
Score: 0.245
-
Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007 Jul 15; 45(2):166-73.
Score: 0.243
-
Concerning diagnosis and management of pacemaker endocarditis. Pacing Clin Electrophysiol. 2007 Jun; 30(6):829; author reply 830.
Score: 0.243
-
Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007 May 08; 49(18):1851-9.
Score: 0.241
-
Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms. Heart Rhythm. 2020 08; 17(8):1393-1397.
Score: 0.148
-
Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes. Pacing Clin Electrophysiol. 2019 10; 42(10):1331-1339.
Score: 0.142
-
Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A?Population-Based Study. JACC Clin Electrophysiol. 2019 09; 5(9):1071-1080.
Score: 0.142
-
Attempted salvage of infected cardiovascular implantable electronic devices: Are there clinical factors that predict success? Pacing Clin Electrophysiol. 2018 05; 41(5):524-531.
Score: 0.129
-
Impact of Abandoned Leads on Cardiovascular Implantable Electronic?Device Infections: A?Propensity Matched Analysis of MEDIC (Multicenter?Electrophysiologic Device Infection?Cohort). JACC Clin Electrophysiol. 2018 02; 4(2):201-208.
Score: 0.126
-
Impacts of a care process model and inpatient electrophysiology service on cardiovascular implantable electronic device infections: a preliminary evaluation. J Interv Card Electrophysiol. 2017 Oct; 50(1):117-124.
Score: 0.124
-
Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression. Clin Infect Dis. 2017 Jun 01; 64(11):1516-1521.
Score: 0.122
-
Reimplantation and Repeat Infection After Cardiac-Implantable Electronic Device Infections: Experience From the MEDIC (Multicenter Electrophysiologic Device Infection Cohort) Database. Circ Arrhythm Electrophysiol. 2017 Mar; 10(3).
Score: 0.119
-
Outcomes of Transvenous Lead Extraction for Cardiovascular Implantable Electronic Device Infections in Patients With Prosthetic Heart Valves. Circ Arrhythm Electrophysiol. 2016 09; 9(9).
Score: 0.115
-
Cardiovascular Implantable Electronic Device Infections due to Propionibacterium Species. Pacing Clin Electrophysiol. 2016 Jun; 39(6):522-30.
Score: 0.113
-
Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry. JACC Cardiovasc Imaging. 2014 Jun; 7(6):541-9.
Score: 0.098
-
Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections. Pacing Clin Electrophysiol. 2014 Aug; 37(8):955-62.
Score: 0.098
-
Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol. 2013 Mar 15; 111(6):874-9.
Score: 0.090
-
Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. Am J Cardiol. 2012 Oct 15; 110(8):1143-9.
Score: 0.087
-
Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol. 2012 Feb 14; 59(7):681-7.
Score: 0.084
-
Cardiac device-related endocarditis complicated by spinal abscess. Pacing Clin Electrophysiol. 2012 Mar; 35(3):269-74.
Score: 0.083
-
Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011 Nov; 8(11):1678-85.
Score: 0.080
-
Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol. 2011 Feb; 34(2):133-42.
Score: 0.077
-
Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol. 2010 Apr; 33(4):407-13.
Score: 0.071
-
Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007 Apr 09; 167(7):669-75.
Score: 0.060
-
Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis. 2006 Sep 15; 43(6):731-6.
Score: 0.057
-
Contemporary management of cardiac implantable electronic device infection. Heart. 2019 06; 105(12):961-965.
Score: 0.034